Insider filing · ROIV
Eric Venker
President & Immunovant CEO
profile →
Roivant Sciences Ltd.
ROIV · Healthcare · 74 filings in 24 months
ticker →
Eric Venker sold $1.2M of Roivant Sciences (ROIV)
Executed Aug 20 2025, disclosed Aug 22 2025, 2 days later.
Value, as filed
$1.2M
100,000 sh × $11.72
Executed
Aug 20 2025
the trade date, as filed
Disclosed
Aug 22 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
EVEric Venker (President & Immunovant CEO) filed 17 Form 4 reports in the trailing twelve months (0 purchases, 17 sales, 1 filed past the two-business-day deadline), most often in Roivant Sciences Ltd. (ROIV). The largest single filing was $7.3M of ROIV (200,000 sh × $36.62, as filed), executed Sep 30.
The name
ROIVHealthcare · Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicine…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Eric Venker in ROIV
ROIVSALE
Roivant Sciences Ltd.
$7.3M200,000 sh × $36.31
Exec Nov 3
Filed Nov 5 · 6:11 PM ET ROIVSALE Roivant Sciences Ltd. $7.3M
200,000 sh × $36.59
Exec Oct 28
Filed Oct 30 · 6:29 PM ET ROIVSALE Roivant Sciences Ltd. $7.0M
200,000 sh across 2 lots
Exec Oct 20
Filed Oct 22 · 6:44 PM ET ROIVSALE Roivant Sciences Ltd. $7.3M
200,000 sh × $36.62
Exec Sep 30
Filed Oct 2 · 5:37 PM ET ROIVSALE Roivant Sciences Ltd. $7.2M
200,000 sh across 2 lots
Exec Aug 28
Filed Sep 1 · 9:00 PM ET ROIVSALE Roivant Sciences Ltd. $7.0M
200,000 sh × $34.95
Exec Jul 27
Filed Jul 29 · 9:00 PM ET ROIVSALE Roivant Sciences Ltd. $6.6M
200,000 sh across 2 lots
Exec Jun 24
Filed Jun 26 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. $6.1M
200,000 sh × $30.27
Exec May 22
Filed May 22 · 5:30 PM ET